Dr. Ahmed Robbie, MD

NPI: 1801826052
Total Payments
$2,143
2020 Payments
$131.56
Companies
34
Transactions
128
Medicare Patients
1,773
Medicare Billing
$181,834

Payment Breakdown by Category

Food & Beverage$2,132 (99.5%)
Gifts$11.24 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,132 127 99.5%
Gift $11.24 1 0.5%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $330.25 20 $0 (2020)
GENZYME CORPORATION $199.89 12 $0 (2019)
PFIZER INC. $164.20 13 $0 (2019)
UCB, Inc. $129.27 9 $0 (2018)
Alexion Pharmaceuticals, Inc. $99.34 2 $0 (2020)
Daiichi Sankyo Inc. $98.96 6 $0 (2018)
LivaNova USA, Inc. $95.56 4 $0 (2019)
Supernus Pharmaceuticals, Inc. $91.95 5 $0 (2019)
Teva Pharmaceuticals USA, Inc. $90.01 6 $0 (2019)
Collegium Pharmaceutical, Inc. $66.32 4 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2020 $131.56 3 Alexion Pharmaceuticals, Inc. ($86.91)
2019 $449.25 25 Novartis Pharmaceuticals Corporation ($108.57)
2018 $746.80 45 UCB, Inc. ($92.83)
2017 $815.84 55 Novartis Pharmaceuticals Corporation ($112.76)

All Payment Transactions

128 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
07/17/2020 Harmony Biosciences LLC Wakix (Drug) Food and Beverage Cash or cash equivalent $24.00 General
Category: Neurological Disorders
02/20/2020 Alexion Pharmaceuticals, Inc. Food and Beverage In-kind items and services $86.91 General
01/06/2020 Novartis Pharmaceuticals Corporation MAYZENT (Drug) Food and Beverage In-kind items and services $20.65 General
Category: NEUROSCIENCE
11/14/2019 Supernus Pharmaceuticals, Inc. OXTELLAR XR (Drug) Food and Beverage Cash or cash equivalent $26.32 General
Category: AED
10/29/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Food and Beverage In-kind items and services $17.82 General
Category: NEUROSCIENCE
09/19/2019 Supernus Pharmaceuticals, Inc. OXTELLAR XR (Drug) Food and Beverage Cash or cash equivalent $11.18 General
Category: AED
08/30/2019 Novartis Pharmaceuticals Corporation MAYZENT (Drug) Food and Beverage In-kind items and services $17.25 General
Category: NEUROSCIENCE
07/25/2019 Novartis Pharmaceuticals Corporation MAYZENT (Drug) Food and Beverage In-kind items and services $14.86 General
Category: NEUROSCIENCE
07/25/2019 Novartis Pharmaceuticals Corporation MAYZENT (Drug) Food and Beverage In-kind items and services $0.94 General
Category: NEUROSCIENCE
07/24/2019 Teva Pharmaceuticals USA, Inc. AJOVY (Drug) Food and Beverage In-kind items and services $11.23 General
Category: Central Nervous System
07/23/2019 Ipsen Biopharmaceuticals, Inc DYSPORT (Drug) Food and Beverage In-kind items and services $16.56 General
Category: Neurology
07/20/2019 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $40.84 General
07/19/2019 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $45.43 General
Category: Immunology
07/16/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Food and Beverage In-kind items and services $16.86 General
Category: NEUROSCIENCE
05/21/2019 Boston Scientific Corporation VERCISE (Device) Food and Beverage In-kind items and services $11.17 General
Category: DBS
05/01/2019 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $17.20 General
Category: Neuroscience
04/30/2019 PFIZER INC. LYRICA (Drug) Food and Beverage In-kind items and services $10.80 General
Category: NEUROSCIENCE;PAIN
04/29/2019 PFIZER INC. LYRICA (Drug), EMBEDA Food and Beverage In-kind items and services $10.80 General
Category: NEUROSCIENCE;PAIN
04/16/2019 GENZYME CORPORATION AUBAGIO (Drug), LEMTRADA Food and Beverage In-kind items and services $22.25 General
Category: MULTIPLE SCLEROSIS
03/20/2019 Teva Pharmaceuticals USA, Inc. AJOVY (Drug) Food and Beverage In-kind items and services $17.48 General
Category: Central Nervous System
03/20/2019 Collegium Pharmaceutical, Inc. XTAMPZA (Drug) Food and Beverage Cash or cash equivalent $16.09 General
Category: Opioid Analgesic
03/07/2019 LivaNova USA, Inc. VNS Therapy (Device) Food and Beverage In-kind items and services $22.02 General
Category: Cardiology/Vascular Diseases
02/28/2019 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $27.86 General
Category: Neuroscience
02/26/2019 Alexion Pharmaceuticals, Inc. SOLIRIS (Drug) Food and Beverage In-kind items and services $12.43 General
Category: Immunology
02/20/2019 GENZYME CORPORATION AUBAGIO (Drug) Food and Beverage In-kind items and services $16.40 General
Category: MULTIPLE SCLEROSIS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 6 360 451 $88,514 $37,728
2022 8 409 487 $128,097 $42,647
2021 9 681 824 $210,023 $69,431
2020 7 323 388 $89,447 $32,028
Total Patients
1,773
Total Services
2,150
Medicare Billing
$181,834
Procedure Codes
30

All Medicare Procedures & Services

30 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 116 118 $29,211 $11,731 40.2%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 70 104 $21,160 $9,453 44.7%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 76 122 $15,264 $7,381 48.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 52 52 $17,464 $6,666 38.2%
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes Facility 2023 30 39 $2,839 $1,483 52.2%
99221 Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes Facility 2023 16 16 $2,576 $1,015 39.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 123 124 $40,344 $12,772 31.7%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 88 135 $29,991 $10,525 35.1%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 39 39 $16,782 $5,719 34.1%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 39 39 $12,715 $4,049 31.8%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 50 72 $12,094 $3,882 32.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 37 44 $9,590 $3,487 36.4%
99221 Initial hospital inpatient care per day, typically 30 minutes Facility 2022 18 18 $3,697 $1,359 36.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 15 16 $2,884 $853.61 29.6%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2021 238 242 $85,624 $25,203 29.4%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 134 205 $42,453 $16,391 38.6%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 151 204 $33,698 $11,387 33.8%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 44 44 $14,300 $4,985 34.9%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 41 52 $10,631 $4,291 40.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 26 26 $13,920 $4,067 29.2%
99219 Hospital observation care, typically 50 minutes Facility 2021 12 12 $4,092 $1,346 32.9%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 20 23 $4,025 $1,284 31.9%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 15 16 $1,280 $476.63 37.2%
99222 Initial hospital inpatient care, typically 50 minutes per day Facility 2020 76 76 $23,351 $8,173 35.0%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 60 87 $17,874 $7,057 39.5%

About Dr. Ahmed Robbie, MD

Dr. Ahmed Robbie, MD is a Neurology healthcare provider based in Joplin, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801826052.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ahmed Robbie, MD has received a total of $2,143 in payments from pharmaceutical and medical device companies, with $131.56 received in 2020. These payments were reported across 128 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($2,132).

As a Medicare-enrolled provider, Robbie has provided services to 1,773 Medicare beneficiaries, totaling 2,150 services with total Medicare billing of $181,834. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Joplin, MO
  • Active Since 07/04/2006
  • Last Updated 01/14/2022
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1801826052

Products in Payments

  • LYRICA (Drug) $150.99
  • GILENYA (Drug) $144.17
  • LEMTRADA (Drug) $120.06
  • VNS Therapy (Device) $95.56
  • AUBAGIO (Drug) $79.83
  • AIMOVIG (Biological) $75.52
  • Movantik (Drug) $70.34
  • Vimpat (Drug) $67.46
  • APTIOM (Drug) $64.59
  • Briviact (Drug) $61.81
  • Betaseron (Drug) $58.99
  • TROKENDI XR (Drug) $54.45
  • MAYZENT (Drug) $53.70
  • AJOVY (Drug) $47.99
  • TALTZ (Drug) $45.43
  • Aimovig (Biological) $43.06
  • NUPLAZID (Drug) $41.91
  • OXTELLAR XR (Drug) $37.50
  • Horizant (Drug) $37.08
  • XTAMPZA (Drug) $32.96

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Joplin